Markedly Elevated Intracranial Pressure Treated With Cranial Vault Expansion,Instead of CSF Shunting,in a Child With Hurler-Scheie Syndrome and Multiple Suture Craniosynostosis
Restricted accessCase reportFirst published online March, 2019
Markedly Elevated Intracranial Pressure Treated With Cranial Vault Expansion,Instead of CSF Shunting,in a Child With Hurler-Scheie Syndrome and Multiple Suture Craniosynostosis
Despite a known association of mucopolysaccharidoses (MPS) and craniosynostosis, treatment of elevated intracranial pressure (ICP) in these patients is primarily cerebrospinal fluid (CSF) shunting. We present a unique case of Hurler-Scheie syndrome with multisuture craniosynostosis and elevated ICP, without ventriculomegaly, where elevated ICP was successfully treated with extensive cranial vault expansion and shunt placement was avoided. Patients with MPS should be evaluated for craniosynostosis, and calvarial vault expansion may be considered as a viable treatment alternative to CSF shunting for elevated ICP in select patients.
AliabadiHReynoldsRPowersCJGrantGFuchsHKurtzbergJ. Clinical outcome of cerebrospinal fluid shunting for communicating hydrocephalus in mucopolysaccharidoses I, II, and III: a retrospective analysis of 13 patients. Neurosurgery. 2010;67(6):1476–1481; discussion 1481-1482.
2.
AppleDJRabbMFWalshPM. Congenital anomalies of the optic disc. Surv Ophthalmol. 1982;27(1):3–41.
3.
ArnPWraithJEUnderhillL. Characterization of surgical procedures in patients with mucopolysaccharidosis type I: findings from the MPS I registry. J Pediatr. 2009;154(6):859–864.e3.
4.
AshworthJLBiswasSWraithELloydIC. Mucopolysaccharidoses and the eye. Surv Ophthalmol. 2006;51(1):1–17.
5.
BaehnerFSchmiedeskampCKrummenauerFMiebachEBajboujMWhybraCKohlschutterAKampmannCBeckM. Cumulative incidence rates of the mucopolysaccharidoses in Germany. J Inherit Metab Dis. 2005;28(6):1011–1017.
6.
BaumVCO’FlahertyJE. Anesthesia for Genetic, Metabolic, and Dysmorphic Syndromes of Childhood. Philadelphia, PA: Lippincott Williams & Wilkins; 2007.
7.
BeckM. Papilloedema in association with Hunter’s syndrome. Br J Ophthalmol. 1983;67(3):174–177.
8.
BeckMColeG. Disc oedema in association with Hunter’s syndrome: ocular histopathological findings. Br J Ophthalmol. 1984;68(8):590–594.
9.
BellewMChumasP. Long-term developmental follow-up in children with nonsyndromic craniosynostosis. J Neurosurg Pediatr. 2015;16(4):445–451.
10.
CollinsMLTraboulsiEIMaumeneeIH. Optic nerve head swelling and optic atrophy in the systemic mucopolysaccharidoses. Ophthalmology. 1990;97(11):1445–1449.
11.
Da CostaACAndersonVAHolmesADLoPWrayACChongDKGreensmithALMearaJG. Longitudinal study of the neurodevelopmental characteristics of treated and untreated nonsyndromic craniosynostosis in infancy. Childs Nerv Syst. 2013;29(6):985–995.
12.
EleyKASheerinFTaylorNWatt-SmithSRGoldingSJ. Identification of normal cranial sutures in infants on routine magnetic resonance imaging. J Craniofac Surg. 2013;24(1):317–320.
13.
FowlerGWSukoffMHamiltonAWilliamsJP. Communicating hydrocephalus in children with genetic inborn errors of metabolism. Childs Brain. 1975;1(4):251–254.
14.
GoldbergMFScottCIMcKusickVA. Hydrocephalus and papilledema in the Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI). Am J Ophthalmol. 1970;69(6):969–975.
15.
GreigAVDunawayDJ. Craniosynostosis. In: FarhadiehRDBulstrodeNWCugnoS, eds. Plastic and Reconstructive Surgery: Approaches and Techniques. Hoboken: John Wiley & Sons; 2015:264–278.
16.
GuptaNRathGPBalaRReddyBKChaturvediA. Anesthetic management in children with Hurler’s syndrome undergoing emergency ventriculoperitoneal shunt surgery. Saudi J Anaesth. 2012;6(2):178–180.
17.
JaneJDumontALinKJaneS. Craniosynostosis. In: MooreAJNewellDW, eds. Neurosurgery: Principles and Practice. New York: Springer; 2007:445–458.
18.
KotagalSBickneseAREswaraMFentonGAGellerTJGrangeDKMartinDSNigroMAPittmanT. Developmental diseases of the nervous system. In: RosenbergRN, ed. Atlas of Clinical Neurology. Philadelphia: Current Medicine; 2003:1–32.
19.
LevittMRHlubekRJMoonKKalaniMYSNakajiPSmithKALittleASKnievelKChanJWMcDougallCG. Incidence and predictors of dural venous sinus pressure gradient in idiopathic intracranial hypertension and non-idiopathic intracranial hypertension headache patients: results from 164 cerebral venograms. J Neurosurg. 2017;126(2):347–353.
20.
ManaraRPrianteEGrimaldiMSantoroLAstaritaLBaroneRConcolinoDDi RoccoMDonatiMAFecarottaS. Brain and spine MRI features of Hunter disease: frequency, natural evolution and response to therapy. J Inherit Metab Dis. 2011;34(3):763–780.
21.
McKusickVA. Heritable Disorders of Connective Tissue. Saint Louis, MO: Mosby; 1972.
22.
MeiklePJHopwoodJJClagueAECareyWF. Prevalence of lysosomal storage disorders. JAMA. 1999;281(3):249–254.
23.
MuenzerJWraithJEClarkeLA. International consensus panel on the management and treatment of mucopolysaccharidosis I. Mucopolysaccharidosis I: management and treatment guidelines. Pediatrics. 2009;123(1):19–29.
24.
PersingJA. MOC-PS(SM) CME article: management considerations in the treatment of craniosynostosis. Plast Reconstr Surg. 2008;121(suppl 4):1–11.
25.
RousseyMLe MarecBFaivreJGandonYLe GallJY, Senecal J. Case of early hydrocephalus in mucopolysaccharidosis type 1 [in French]. Pediatrie. 1983;38(4):243–248.
26.
SchumacherRGBrzezinskaRSchulze-FrenkingGPitzS. Sonographic ocular findings in patients with mucopolysaccharidoses I, II and VI. Pediatr Radiol. 2008;38(5):543–550.
27.
SheridanMJohnstonI. Hydrocephalus and pseudotumour cerebri in the mucopolysaccharidoses. Childs Nerv Syst. 1994;10(3):148–150.
28.
ShinnarSSingerHSValleD. Acute hydrocephalus Hurler’s syndrome. Am J Dis Child. 1982;136(6):556–557.
29.
TuiteGFChongWKEvansonJNaritaATaylorDHarknessWFJonesBMHaywardRD. The effectiveness of papilledema as an indicator of raised intracranial pressure in children with craniosynostosis. Neurosurgery. 1996;38(2):272–278.
30.
UsuiTShirakashiMTakagiMAbeHIwataK. Macular edema-like change and pseudopapilledema in a case of Scheie syndrome. J Clin Neuroophthalmol. 1991;11(3):183–185.
31.
Van AerdeJCampbellA. Hydrocephalus and shunt placement. Am J Dis Child. 1983;137(2):187–188.
32.
WilsonSHashamiyanSClarkeLSaftigPMortJDejicaVMBrommeD. Glycosaminoglycan-mediated loss of cathepsin K collagenolytic activity in MPS I contributes to osteoclast and growth plate abnormalities. Am J Pathol. 2009;175(5):2053–2062.
33.
WinterRMBaraitserM. Multiple Congenital Anomalies: A Diagnostic Compendium. Dordrecht, the Netherlands: Springer-Science+Business Media, B.V; 2013.
34.
YatzivSEpsteinCJ. Hunter syndrome presenting as macrocephaly and hydrocephalus. J Med Genet. 1977;14(6):445–447.
35.
YoungIDHarperPS. Mild form of Hunter’s syndrome: clinical delineation based on 31 cases. Arch Dis Child. 1982;57(11):828–836.
36.
ZiyadehJLe MerrerMRobertMArnaudEValayannopoulosVDi RoccoF. Mucopolysaccharidosis type I and craniosynostosis. Acta Neurochir (Wien). 2013;155(10):1973–1976.
